文献速递膀胱癌与上尿路尿路上皮癌

英格兰膀胱癌根治性膀胱切除术的集中化:改善结局指南发布十年后的超级集中化论证

Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation.
PubMed 文献 · BJU Int · 2017-07-10

分析2003至2014年英格兰膀胱癌根治性膀胱切除术集中化对术后死亡率、住院时间、并发症和再干预率的影响。共识别15 292例手术,不符合指南的比例从65%降至12.4%,30天死亡率从2.7%降至1.5%(P=0.024)。符合指南的手术30天死亡率、1年死亡率、住院时间和再干预率均更优。

要点

  • 不符合指南的根治性膀胱切除术比例从65%降至12.4%,30天死亡率从2.7%降至1.5%(P=0.024)。
  • 符合指南的手术30天死亡率为2.1% vs 不符合者2.9%(P=0.003),1年死亡率为21.5% vs 25.6%(P<0.001)。
  • 每中心每年每增加一台手术,30天死亡 odds 降低1.5%(OR 0.985,95%CI 0.977-0.992),1年死亡 odds 降低1%(OR 0.990,95%CI 0.988-0.993)。

核心结论

  • 集中化自2002年指南发布后已在英格兰实施,结局改善,包括每中心每年每增加一台手术即可显著降低死亡率和再干预率,可为医疗规划者提供证据基础以提出进一步优化手术服务的新指南,并让其他医疗系统看到这种广泛的机构变革是可行且积极的。

研究设计与样本

  • 基于医院 Episode 统计(HES)数据,分析2003/2004至2013/2014年英格兰因膀胱癌行根治性膀胱切除术的病例,采用多变量统计分析描述每位外科医生及服务提供者年手术量与死亡率的关系。

主要发现

  • 共识别15 292例根治性膀胱切除术。
  • 不符合改善结局指南(IOG)指南的手术比例从65%降至12.4%,对应30天死亡率从2.7%降至1.5%(P=0.024)。
  • 符合IOG指南的手术相比不符合者,30天死亡率更低(2.1% vs 2.9%;P=0.003),1年死亡率更低(21.5% vs 25.6%;P<0.001),住院时间更短(14 vs 16天;P<0.001),再干预率更低(30.0% vs 33.6%;P<0.001)。
  • 每中心每年每增加一台手术,30天死亡 odds 降低1.5%(OR 0.985,95%CI 0.977-0.992),1年死亡 odds 降低1%(OR 0.990,95%CI 0.988-0.993),并显著降低再干预率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyse the impact of centralisation of radical cystectomy (RC) provision for bladder cancer in England, on postoperative mortality, length of stay (LoS), complications and re-intervention rates, from implementation of centralisation from 2003 until 2014. In 2002, UK policymakers introduced the 'Improving Outcomes Guidance' (IOG) for urological cancers after a global cancer surgery commission identified substantial shortcomings in provision of care of RCs. One key recommendation was centralisation of RCs to high-output centres. No study has yet robustly analysed the changes since the introduction of the IOG, to assess a national healthcare system that has mature data on such institutional transformation. PATIENTS AND METHODS: RCs performed for bladder cancer in England between 2003/2004 and 2013/2014 were analysed from Hospital Episode Statistics (HES) data. Outcomes including 30-day, 90-day, and 1-year all-cause postoperative mortality; median LoS; complication and re-intervention rates, were calculated. Multivariable statistical analysis was undertaken to describe the relationship between each surgeon and the providers' annual case volume and mortality. RESULTS: In all, 15 292 RCs were identified. The percentage of RCs performed in discordance with the IOG guidelines reduced from 65% to 12.4%, corresponding with an improvement in 30-day mortality from 2.7% to 1.5% (P = 0.024). Procedures adhering to the IOG guidelines had better 30-day mortality (2.1% vs 2.9%; P = 0.003) than those that did not, and better 1-year mortality (21.5% vs 25.6%; P < 0.001), LoS (14 vs 16 days; P < 0.001), and re- intervention rates (30.0% vs 33.6%; P < 0.001). Each single extra surgery per centre reduced the odds of death at 30 days by 1.5% (odds ratio [OR] 0.985, 95% confidence interval [CI] 0.977-0.992) and 1% at 1 year (OR 0.990, 95% CI 0.988-0.993), and significantly reduced rates of re-intervention. CONCLUSION: Centralisation has been implemented across England since the publication of the IOG guidelines in 2002. The improved outcomes shown, including that a single extra procedure per year per centre can significantly reduce mortality and re-intervention, may serve to offer healthcare planners an evidence base to propose new guidance for further optimisation of surgical provision, and hope for other healthcare systems that such widespread institutional change is achievable and positive.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Afshar M, Goodfellow H, Jackson-Spence F, et al. Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation. BJU Int. 2017. PMID: 28594471. doi:10.1111/bju.13929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。